Maplight Therapeutics, Inc. · NASDAQ:MPLT

Kroeger Christopher A. sold 19,187 Maplight Therapeutics, Inc. shares (Form 4)

Traded Apr 15 to Apr 16, 2026 · Filed Apr 17, 2026

From Apr 15 to Apr 16, 2026, Kroeger Christopher A. (Director, Chief Executive Officer) sold 19,187 Maplight Therapeutics, Inc. shares at an average US$27.16 for US$521K, leaving 1,630,564 shares. Filed Apr 17, 2026 (Form 4).

Sold
19,187 shares
Price
US$27.16 average (US$26.93 to US$27.49)
Value
US$521K
Holding after
1,630,564 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Voting Common StockSale9,135US$26.931,640,616Direct
Apr 16, 2026Voting Common StockSale2,477US$27.011,638,139Direct
Apr 16, 2026Voting Common StockSale7,575US$27.491,630,564Direct

Source

View original at SEC

Related